These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Human umbilical cord vein as arterial substitute in the dog. Karvonen E; Harjula A; Meurala H; Harjola PT Ann Chir Gynaecol; 1981; 70(2):61-4. PubMed ID: 6459050 [TBL] [Abstract][Full Text] [Related]
8. Biodegradation and aneurysm formation in umbilical vein grafts. Observations and a realistic strategy. Dardik H; Ibrahim IM; Sussman B; Kahn M; Sanchez M; Klausner S; Baier RE; Meyer AE; Dardik II Ann Surg; 1984 Jan; 199(1):61-8. PubMed ID: 6691733 [TBL] [Abstract][Full Text] [Related]
9. Comparative decades of experience with glutaraldehyde-tanned human umbilical cord vein graft for lower limb revascularization: an analysis of 1275 cases. Dardik H; Wengerter K; Qin F; Pangilinan A; Silvestri F; Wolodiger F; Kahn M; Sussman B; Ibrahim IM J Vasc Surg; 2002 Jan; 35(1):64-71. PubMed ID: 11802134 [TBL] [Abstract][Full Text] [Related]
10. Glutaraldehyde pre-treated human saphenous and umbilical veins as xenogeneic small vessel substitutes and shunts in dogs. Harjula A Ann Chir Gynaecol; 1981; 70(1):11-7. PubMed ID: 7259055 [TBL] [Abstract][Full Text] [Related]
11. Graft type for femoro-popliteal bypass surgery. Mamode N; Scott RN Cochrane Database Syst Rev; 2000; (2):CD001487. PubMed ID: 10796649 [TBL] [Abstract][Full Text] [Related]
12. A clinicopathologic study of aneurysm formation of glutaraldehyde-tanned human umbilical vein grafts. Miyata T; Tada Y; Takagi A; Sato O; Oshima A; Idezuki Y; Shiga J J Vasc Surg; 1989 Dec; 10(6):605-11. PubMed ID: 2585648 [TBL] [Abstract][Full Text] [Related]
13. Early aneurysmal degeneration of human umbilical vein bypass grafts. Layer GT; King RB; Jamieson CW Br J Surg; 1984 Sep; 71(9):709-10. PubMed ID: 6478164 [TBL] [Abstract][Full Text] [Related]